Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
Abstract Here I review the scientific background, current stage of development and future perspectives that I foresee in the field of genetic manipulation of hematopoietic stem cells with a special emphasis on clinical applications.
Main Author: | Luigi Naldini |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2019-03-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201809958 |
Similar Items
-
Development and recent progresses of gene therapy for β-thalassemia
by: Santina Acuto, et al.
Published: (2014-09-01) -
HEMATOPOIETIC STEM CELL GENE THERAPY FOR INHERITED MONOGENIC DISEASES AND ITS IMPLICATIONS FOR FUTURE GENE THERAPY TRIALS IN TURKEY
by: Fatima Aerts-kaya, et al.
Published: (2019-02-01) -
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
by: Francesco Piras, et al.
Published: (2017-09-01) -
Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE
by: Rana Yadak, et al.
Published: (2018-03-01) -
Gene Therapies for Primary Immune Deficiencies
by: Lisa A. Kohn, et al.
Published: (2021-02-01)